Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amaryl M vs Amaryl in T2DM
NCT01457911Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2011
- Primary completion
- Feb 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of glimepiride, liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Oct 2011; status: completed.
02
Drugs
glimepirideliquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01457911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01457911.